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Abstract
Objectives: Cigarette smoking has been reported to cause
acute blood pressure elevation. Therefore, it is important
to assess the relationships between chronic smoking and
blood pressure, body composition, and the metabolic
profile to gain an understanding of the long-term effects
of smoking on an individual’s body weight and health.
This study examined the relationships between the hair
nicotine level, blood pressure, body composition, lipid
profile, and leptin in healthy male smokers.
Methods: For this cross-sectional study, 107 male
smokers aged between 20 and 50 years old were recruited
as volunteers. The nicotine levels in the volunteers’ hair
were measured using gas chromatography-mass spec-
trometry. Moreover, the subjects’ blood pressure, body
composition (weight, height, body mass index, body fat
percentage, visceral fat, waist and hip circumferences,
and basal metabolic rate), lipid profile, and leptin con-
centration were also measured.y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2015.11.007
Z.B. Sanip et al. 51Results: The means for age and BMI among the subjects
were 37.00 (9.42) years and 24.59 (4.33) kg/m2, respec-
tively. The average length of time as a smoker was 16.91
years. The hair nicotine level was found to be positively
correlated with the total cholesterol (r ¼ 0.314,
r2 ¼ 0.099, p ¼ 0.028) and triglyceride (r ¼ 0.351,
r2 ¼ 0.0.123, p ¼ 0.013) levels. However, no significant
correlations were found between the hair nicotine level
and blood pressure, body composition, or leptin
concentration.
Conclusion: The positive correlations between the hair
nicotine level and total cholesterol and triglyceride levels
highlighted the harmful effects of chronic smoking, even
among healthy male subjects.
Keywords: Blood pressure; Body composition; Metabolic
profile; Nicotine; Smoking
 2015 The Authors.
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It has been well-established that smoking and obesity are
significant causes of preventable morbidity and mortality.1,2
For many years, smoking and obesity have posed a global
growing public health burden. Deaths attributed to
tobacco use have been estimated to increase annually, with
low- and middle-income countries being the most affected.2
Furthermore, both smoking and obesity have been revealed
as modifiable factors that promote the development of
cardiovascular disease (CVD). In fact, a vast amount of
evidence supports the association between cigarette
smoking and CVD, and smoking trends at present can
determine how heavy the health burden of CVD will be
among future communities.3 Similarly, smoking has also
been reported to increase blood pressure (BP) in smokers.4
However, this finding remains controversial, as results
showing similar or lower BP in smokers compared to non-
smokers have also been reported in some epidemiological
studies.5,6
Moreover, the relationship between smoking and obesity
is complex and currently not well understood. In fact, several
studies have reported that nicotine intake reduces food
intake, increases energy expenditure, and decreases weight,
whereas smoking cessation has been related to hyperphagia
and weight gain.7 Furthermore, a previous study indicated
that tobacco users have a lower body mass index (BMI), a
smaller waist circumference (WC), and a lower body fat
percentage (BF) compared to non-tobacco users,8 whereas
other reports have indicated that smoking does not
increase one’s overall fatness, but does significantly
increase abdominal and visceral obesity.9,10
Meanwhile, leptin, an adipocyte-derived signal molecule,
interacts with specific receptors located in the central neuralsystem and peripheral tissues and results in decreased food
intake and increased energy expenditure.11 Nevertheless,
whether leptin concentration is affected by smoking has
not been conclusively determined, as previous studies have
produced varying findings pertaining to the association
between smoking and leptin.12e14
Additionally, many studies in this area have used self-
reporting data, such as the number of cigarettes smoked or
packs per day, to identify an individual’s smoking status. In
this study, however, hair nicotine levels were employed as a
biomarker to represent subjects’ smoking status. Moreover,
the relationships between the hair nicotine levels and the BP,
body composition, lipid profile, and leptin concentration
among smokers have not been previously examined. There-
fore, in the present work, the relationships between the hair
nicotine levels and the BP, body composition, lipid profile,
and leptin concentration are examined in healthy male
smokers.
Materials and Methods
Subjects
This cross-sectional study was conducted at the School of
Medical Sciences, Universiti Sains Malaysia, Kubang Ker-
ian, Kelantan, from January to December 2012. One-
hundred-seven active Malay male smokers participated in
this study. All of the subjects were generally healthy: they
had no history of chronic disease, were non-obese
(BMI < 30 kg/m2), were not on routine medications, and
did not consume alcohol. However, subjects who had
participated in weight loss and/or smoking cessation pro-
grammes were excluded from this study. The protocol of this
study was approved by the Research Ethics Committee
(Human) of Universiti Sains Malaysia and was conducted in
accordance with the Helsinki Declaration. Additionally,
written informed consent was obtained from all subjects
prior to their participation in the study. Personal back-
ground information and smoking history were obtained
through interview sessions.
Blood collection, blood pressure and body composition
All eligible subjects were requested to fast overnight
before the measurement day. That morning, peripheral
blood samples were collected and allowed to clot at room
temperature before undergoing a serum separation process.
The systolic and diastolic blood pressures (SBP &DBP) were
measured on the right arm in the sitting position using an
automatic digital blood pressure monitor (HEM-780,
Omron, Japan) after 10 min of rest. Height was measured
from the standing position using a portable body meter (206,
Seca, Germany), and weight, body mass index (BMI), body
fat percentage (BF), visceral fat (VF), and basal metabolic
rate (BMR) were measured using a digital body composition
analyser (SC-330, Tanita, Japan) that applied the principles
of bioelectrical impedance analysis (BIA). Furthermore,
waist and hip circumferences (WC & HC) were measured
using body tape at the midway point between the lower rib
margin and the iliac crest and at the maximal circumference
over the buttocks, respectively, from the standing position.
Table 1: Basic characteristics of subjects.
Parameters Value*
Age (years) 37 (9.42)
Smoking period (years) 16.91 (7.74)
Systolic blood pressure (mmHg) 125.32 (14.37)
Diastolic blood pressure (mmHg) 77.09 (11.59)
Body weight (kg) 70.02 (12.45)
Body height (m) 1.68 (0.07)
Body mass index (kg/m2) 24.81 (3.73)
Waist circumference (cm) 83.92 (11.85)
Hip circumference (cm) 96.81 (7.53)
Waist-hip ratio 0.87 (0.06)
Body fat percentage (%) 21.80 (6.42)
Visceral fat percentage (%) 9.79 (4.43)
Basal metabolic rate (kcal) 1523.84 (205.95)
Total cholesterol (mmol/l) 5.16 (1.04)
Triglyceride (mmol/l) 1.60 (0.87)
High-density lipoprotein cholesterol (mmol/l) 1.14 (0.20)
Low-density lipoprotein cholesterol (mmol/l) 3.30 (0.79)
Serum leptin (ng/ml) 4.31 (1.99)
Hair nicotine (ng/mg) 7.16 (10.05)
*Data are expressed as the means (SD).
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Serum samples and aliquots for determining the lipid
profile and leptin concentration were separated from clotted
blood via centrifugation and stored at80 C until analysed.
Total cholesterol (TC), triglyceride (TG), and high-density
lipoprotein cholesterol (HDL-C) were analysed using an
automated biochemistry analyser (Vitalab Selectra E,
Netherlands). The TC level was measured via the cholesterol
oxidase-peroxidase (CHOD-PAD) colorimetric method
(Randox, UK), whereas TG was estimated according to the
glycerol oxidase-peroxidase (GPO-PAP) colorimetric
method (Randox, UK). HDL-C was estimated using a direct
clearance method (Randox, UK), and low-density lipopro-
tein cholesterol (LDL-C) was calculated according to the
following equation: [TC (mmol/l)  HDL-C (mmol/l)  TG
(mmol/l)/2.2].15 Serum leptin was measured in duplicate
using commercial 96-well enzyme-linked immunosorbent
assay (ELISA) kits (Cusabio, China), which were based on
the direct sandwich ELISA technique. Moreover, the optical
density was determined using a microplate reader (Varioskan
Flash, Thermo Scientific, USA) at 450 nm, whereas a stan-
dard curve of four parameter logistic (4-PL) curve-fits was
generated using SkanIt software (SkanIt Software 2.4.3,
Thermo Scientific, USA).
Hair nicotine
Hair nicotine levels were examined at the National Poison
Centre (PRN), Universiti Sains Malaysia, Pulau Pinang,
using gas chromatography-mass spectrometry (GCMS)
analysis, as previously mentioned.16 The vortex posterior
hair samples were cut as close as possible to the scalp, and
only 10 cm (maximum length) of each hair sample
(measured from the scalp end) was used for the hair
nicotine analysis. The analysis involved hair sampling,
washing, digestion, extraction, and measurement.
Statistical analysis
Statistical analysis of the data was performed using IBM
SPSS Statistics software (Version 20, IBM, USA). The data
are shown as the means (SD), and a p value less than 0.05 was
considered statistically significant. The relationships between
the hair nicotine level and the serum leptin, BP, body
composition, and lipid profile were determined using a sim-
ple linear regression analysis.
Results
The mean age and BMI for the one-hundred-seven male
smoker subjects were 37 (9.42) years old and 24.81 (3.73) kg/
m2, respectively, and the subjects had an average smoking
duration of 16.91 (7.74) years. Forty-three subjects (40.2%)
smoked 10 or fewer cigarettes per day; fifty-five subjects
(51.4%) smoked 11e20 cigarettes per day; seven subjects
(6.5%) smoked 21e30 cigarettes per day, and two subjects
(1.9%) smoked more than 30 cigarettes per day. The per-
sonal background descriptions of the subjects are portrayed
in Table 1, and Figure 1 illustrates the relationships between
hair nicotine levels and TC and TG. Significant positiverelationships were revealed between hair nicotine levels and
TC (r ¼ 0.314, r2 ¼ 0.099, p ¼ 0.028) and TG (r ¼ 0.351,
r2 ¼ 0.0.123, p ¼ 0.013). Nonetheless, no significant
relationships were found between hair nicotine levels and
BP, body composition, or leptin concentration.Discussion
The present study demonstrated that hair nicotine levels
were related to TC and TG. However, there were no signif-
icant relationships between hair nicotine levels and BP, body
composition, or serum leptin.
Since the presence of nicotine was first discovered in hu-
man hair in 1983, many studies have employed hair as a
research medium, thus proving the usefulness and reliability
of the hair nicotine parameter for measuring nicotine expo-
sure in both active and passive smokers.16e18 Due to the
shorter half-lives of the biomarkers measured from urine,
saliva or serum, hair nicotine analysis provides better infor-
mation on long-term (up to several months) active or passive
smoking exposure.Moreover, hair can be easily collected and
immediately stored without deterioration at a minimal cost.18
Thus, hair nicotine analysis appears to be reliable and efficient
for the measurement of nicotine exposure in humans.
In this study, no significant relationships were discovered
between hair nicotine levels and SBP or DBP. Similarly,
another research group found that SBP was not significantly
different in a younger (16e45 years old) smokers’ group
compared to non-smokers, nor were there differences
detected in DBP between younger and older (45 years old)
smokers’ groups compared with non-smokers.19 Meanwhile,
a study of Japanese smokers found no significant correlation
between BP and smoking amount,6 particularly in normal
weight smokers.19 Our subjects’ backgrounds were quite
similar to those of the Japanese subjects in this study19: our
subjects were healthy and non-obese, with a mean BMI of
24.81 (3.73), and the majority were less than 45 years old.
Figure 1: Relationship between the hair nicotine level and total cholesterol and triglyceride levels.
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smoker subjects given the lack of a significant association
between BP and the chronic smoking habit. On the contrary,
however, chronic smoking has been reported to increase
aortic SBP in chronic smokers compared to non-smokers,4
and it was also associated with uncontrolled hypertension
among previously diagnosed hypertensive patients.20 On
the other hand, SBP and DBP were also found to be lower
in smokers than in non-smokers.6 In fact, similar findings
have been reported by several groups, which reveals an
inconsistent association between smoking and BP among
smokers with different classes of BMI (normal, overweight,
and obese).5 In addition to age and BMI, factors such as
alcohol consumption, habitual exercise, and dietary intake
may contribute to the conflicting results from studies on
smoking and BP.6 Although, the effects of smoking on BP
seem rather contradictory, it has been well-established that
smoking is a major risk factor in the development and pro-
gression of CVD,21 and harmful effects of smoking on other
cardiovascular risk factors, such as arterial stiffness, have
also been reported.4
In the present study, no correlation was identified between
hair nicotine levels and body composition, which includes
factors such as weight, BMI, WC, HC, WHR, BF, and VF.
This finding is in accordance with many others from previous
studies. For example, in a population-based survey of
middle-aged Caucasians, Clair et al. (2011) found an insig-
nificant association between smoking (defined as a cigarette
smoked daily) and BMI.8 Likewise, a study of male Korean
smokers found that there were no dose-dependent associa-
tions observed with BMI and BF.9 Yet another study
reported no difference in the mean BMI between smokers
and non-smokers, regardless of gender.22 However, the
relationship between smoking and obesity indices,
especially in terms of body composition, is more complex.
Contrary to our results, Canoy et al. (2005) demonstrated
that smokers had a lower BMI, WC, and BF than non-
smokers10; on the other hand, a study of Japanese men
showed that obese smokers had a higher WC compared to
obese non-smokers.23 Furthermore, the associations
between smoking amount and BMI, WC, WHR, BF and
VF have been reported to be dose-dependent insofar as an
increased smoking amount contributes to increases in the
levels of these obesity indices among smokers.8,9,24Although, there was a lack of association between hair
nicotine levels and body composition in this study, signifi-
cant positive relationships were revealed between hair nico-
tine levels and TC and TG. In accordance with these findings,
previous studies have discovered higher concentrations of
TC, TG, and LDL-C and a lower concentration of HDL-C
in smokers compared to non-smokers.25,26 Moreover, Joshi
et al. (2013) found that in male Indian smokers, the
concentrations of TC, TG, and LDL-C parallelled the
severity or level of smoking,25 whereas TC and LDL-C were
reported to be strongly correlated with the smoking levels of
Greek smokers.27 These findings suggest that smoking may
contribute to dyslipidaemia in smokers, thus leading to the
development of atherosclerosis and an increased risk of
CVD.25
Furthermore, several mechanisms for the modification of
lipid levels in smokers have been described. First, nicotine
can increase the secretion of catecholamine by the sympa-
thetic adrenal system. This condition is followed by the
synthesis and secretion of hepatic free fatty acids, TG, and
very low-density lipoprotein cholesterol (VLDL-C) into the
blood stream.28 Additionally, smoking also induces the
reduction of lipolysis enzymes, such as lipoprotein lipase
(LPL) activity, in adipose and muscular tissue, thus
reducing TG hydrolysis and clearance. Moreover, previous
studies have proven that there is a TG metabolism
disturbance in adipose tissue and reduced activity of LPL
in the skeletal muscle of chronic smokers compared to non-
smokers.29,30 Finally, smoking also reduces LPL activity
through hyperinsulinemia,31 thus decreasing TG hydrolysis
and leading to an increase of TG levels in smokers.
Nicotine administration has been reported to reduce food
intake, increase energy expenditure, and decrease weight,
whereas smoking cessation has been linked to hyperphagia
and weight gain.7 Nicotine may act directly on the
hypothalamus, thus influencing the regulation of energy
intake and expenditure.32 However, the effect of chronic
smoking or nicotine itself on leptin, an appetite-suppressing
factor, may also offer an explanation for the influence of
smoking on body weight. In the present study, no significant
relationship was identified between hair nicotine levels and
leptin concentration. This finding is in accordance with pre-
vious studies, which reported no relationship between
smoking and leptin in smokers, non-smokers, or ex-smokers,
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smokers and non-smokers have shown no significant differ-
ence in leptin levels for either group.13,34
Confusingly, two studies found higher leptin levels in
smokers compared to non-smokers,14,35 whereas other
studies portrayed lower leptin levels in smokers than in non-
smokers.12,36,37 Therefore, it may be concluded that chronic
smoking may affect the leptin concentration in smokers in
several ways. Smoking may increase leptin secretion from
adipose tissue and decrease leptin clearance, thus resulting
in a higher leptin concentration.38 Smoking may also cause
leptin insensitivity in the hypothalamus, thus disturbing the
leptin feedback loop and leading to a subsequent
compensatory increase in leptin production.35 However,
reduced leptin levels among smokers may be due to an
indirect effect of nicotine increasing the catecholamine
concentration, which is believed to inhibit leptin expression
and secreation.37 Due to these mixed findings, there is
currently no single claim that can adequately represent the
relationship between smoking and leptin levels. The actual
relationship may vary based on factors related to dose,
time, administration route, study design, and population.37
Nonetheless, we found no significant relationship between
smoking and leptin levels among our subjects. The reasons
for this are unclear, but it is worthwhile to consider that
smoking may not have direct effects on leptin in such a way
that can easily explain the association between smoking and
decreased weight or reduced food intake among smokers.13
It must be noted that some of the limitations in this study
might have influenced the findings. First, the number of
subjects was small and might not reflect the exact makeup of
smokers in the population. This also may contribute to the
lack of association between hair nicotine levels and blood
pressure, body composition, and leptin. Second, other fac-
tors might affect the obesity indices and leptin concentration
among smokers, such as physical activity (PA), diet, hor-
mones, and inflammatory markers.36 These factors were not
measured. For example, PA has been reported to decrease
body weight and inversely correlate with the leptin
concentration.39,40 On the other hand, the strength of this
study is based on employing a smoking biomarker, hair
nicotine levels, rather than using self-reported information,
such as cigarettes smoked per day or packs per day, to
represent smoking activity. The hair nicotine level is likely a
more reliable marker in determining the smoking amount.
This study choice eliminated any possible biased information
in terms of smoking activity.Conclusion
In conclusion, the positive relationship between hair
nicotine levels and TC and TG suggested harmful effects of
chronic smoking even in generally healthy male subjects.
Therefore, the promotion of and assistance with smoking
cessation are among the best methods for reducing the
harmful effects of smoking.Conflict of interest
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